Respir Physiol Neurobiol. 2013 Jan 15;185(2):332-8. doi: 10.1016/j.resp.2012.09.009. Epub 2012 Oct 8.

中文速读

本研究针对肝肺综合征(HPS)相关的肺动脉平滑肌细胞(PASMCs)增殖,使用Entranster-R4000转染ANXA2 siRNA,发现敲低ANXA2可抑制HPS大鼠血清诱导的PASMCs增殖及ERK1/2和NF-κB信号通路激活,提示ANXA2是潜在治疗靶点。

体外(细胞)siRNAPASMCs

本文使用:小核酸转染试剂Entranster™-R4000

查看产品详情(含全部 223 篇文献) →

Effect of annexin A2 on hepatopulmonary syndrome rat serum-induced proliferation of pulmonary arterial smooth muscle cells.

Zeng J1, Yi B, Wang Z, Ning J, Wang X, Lu K.

Author information

1Department of Anesthesia, Southwest Hospital, the Third Military Medical University, Chongqing 400038, China.

Abstract

Hepatopulmonary syndrome (HPS) is characterizes by an arterial oxygenation defect induced by intrapulmonary vasodilation that increase morbidity and mortality. However, the underlying mechanisms on HPS-associated pulmonary vascular remodeling remains undefined. In this study, we found that HPS rat serum, drawn from common bile duct ligation (CBDL) rats, mediated the overexpression of ANXA2 and the proliferation of PASMCs. And small interfering RNA (siRNA) that target rat ANXA2 led to significant downregulation of ANXA2, which resulted in the decreased proliferation of PASMCs. Subsequently, we further examined the role of ANXA2 siRNA in the regulation of pro-proliferative signaling such as that mediated by ERK1/2 and NF-κB, and found the attenuation of HPS-associated activation of the signaling pathway. Thus, the fact highlighted the crucial role of ANXA2 in HPS-associated PASMC proliferation, and suggested a potential therapeutic effect on HPS-associated pulmonary vascular remodeling.

本文使用的产品

小核酸转染试剂Entranster™-R4000

已有 223 篇已发表文献

查看产品详情(含全部 223 篇文献) →

热线电话
  • 010-60535354
微信客服二维码 微信扫一扫,加微信客服
0
0
我的购物车
购物车是空的去下单